Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
European Journal of Immunology
|
August 13, 2004
Interleukin-2 is essential for CD4+CD25+ regulatory T cell function
Maurus de la Rosa, Sascha Rutz, Heike Dorninger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2010
Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments
Dorothea Busse, Maurus de la Rosa, Kirstin Hobiger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 21, 2002
Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells
Joachim Lehmann, Jochen Huehn, Maurus de la Rosa, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 4, 2020
Blockade of the costimulatory CD28-B7 family signal axis enables repeated application of AAV8 gene vectors
Marco Frentsch, Alberto Sada Japp, Manuela Dingeldey, et al.
European Journal of Immunology
|
May 22, 2008
IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells
Susan Brandenburg, Takeshi Takahashi, Maurus de la Rosa, et al.
Molecular Therapy. Methods & Clinical Development
|
July 25, 2019
Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors
Anita Kruzik, Damir Fetahagic, Bettina Hartlieb, et al.
Pharmaceutical Research
|
June 9, 2016
The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
Christian Lubich, Peter Allacher, Maurus de la Rosa, et al.
Molecular Therapy. Methods & Clinical Development
|
October 4, 2023
Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium
Marion David, Davide Monteferrario, Gaëlle Saviane, et al.
Pharmaceutical Research
|
June 19, 2013
Development of a transgenic mouse model with immune tolerance for human coagulation factor VIIa
Christine Lenk, Sabine Unterthurner, Maria Schuster, et al.
Human Gene Therapy Methods
|
February 9, 2019
Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive <i>In Vitro</i> Assays
Anita Kruzik, Herwig Koppensteiner, Damir Fetahagic, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
European Journal of Immunology
|
August 13, 2004
Interleukin-2 is essential for CD4+CD25+ regulatory T cell function
Maurus de la Rosa, Sascha Rutz, Heike Dorninger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2010
Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments
Dorothea Busse, Maurus de la Rosa, Kirstin Hobiger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 21, 2002
Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells
Joachim Lehmann, Jochen Huehn, Maurus de la Rosa, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 4, 2020
Blockade of the costimulatory CD28-B7 family signal axis enables repeated application of AAV8 gene vectors
Marco Frentsch, Alberto Sada Japp, Manuela Dingeldey, et al.
European Journal of Immunology
|
May 22, 2008
IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells
Susan Brandenburg, Takeshi Takahashi, Maurus de la Rosa, et al.
Molecular Therapy. Methods & Clinical Development
|
July 25, 2019
Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors
Anita Kruzik, Damir Fetahagic, Bettina Hartlieb, et al.
Pharmaceutical Research
|
June 9, 2016
The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
Christian Lubich, Peter Allacher, Maurus de la Rosa, et al.
Molecular Therapy. Methods & Clinical Development
|
October 4, 2023
Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium
Marion David, Davide Monteferrario, Gaëlle Saviane, et al.
Pharmaceutical Research
|
June 19, 2013
Development of a transgenic mouse model with immune tolerance for human coagulation factor VIIa
Christine Lenk, Sabine Unterthurner, Maria Schuster, et al.
Human Gene Therapy Methods
|
February 9, 2019
Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive <i>In Vitro</i> Assays
Anita Kruzik, Herwig Koppensteiner, Damir Fetahagic, et al.
Page
of 2